Insider Trading - Brady Todd C

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Brady Todd C

Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2017-02-17
Purchase		 2017-02-21
4:32 pm		 Aldeyra Therapeutics Inc. ALDX Brady Todd C
CEO		 22,223 $4.5 $100,004 64,408
(Direct)		 View
2019-09-09
Purchase		 2019-09-11
4:05 pm		 Aldeyra Therapeutics Inc. ALDX Brady Todd C
CEO		 20,000 $5.1412 $102,824 578,991
(Direct)		 View
2019-09-13
Purchase		 2019-09-17
07:35 am		 Aldeyra Therapeutics Inc. ALDX Brady Todd C
CEO		 13,000 $5.8454 $75,990 591,991
(Direct)		 View
2019-09-13
Purchase(A)		 2019-09-17
4:21 pm		 Aldeyra Therapeutics Inc. ALDX Brady Todd C
CEO		 21,547 $5.9149 $127,449 600,538
(Direct)		 View
2019-09-18
Purchase		 2019-09-20
07:37 am		 Aldeyra Therapeutics Inc. ALDX Brady Todd C
CEO		 14,288 $5.9116 $84,465 614,826
(Direct)		 View
2019-09-23
Purchase		 2019-09-25
07:40 am		 Aldeyra Therapeutics Inc. ALDX Brady Todd C
CEO		 8,680 $5.8102 $50,433 623,506
(Direct)		 View
2019-09-30
Purchase		 2019-10-02
07:36 am		 Aldeyra Therapeutics Inc. ALDX Brady Todd C
CEO		 8,710 $5.6812 $49,483 632,216
(Direct)		 View
2019-12-16
Purchase		 2019-12-18
07:35 am		 Aldeyra Therapeutics Inc. ALDX Brady Todd C
CEO		 20,000 $5.0954 $101,908 652,216
(Direct)		 View
(A) Indicate amendment filing.

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2016-11-09
Conversion		 2016-11-14
6:15 pm		 N/A
N/A		 Oncobiologics Inc. ONS Brady Todd C
Director		 28,985 $0 28,985
(Direct)		 View
2016-11-09
Exercise		 2016-11-14
6:15 pm		 N/A
N/A		 Oncobiologics Inc. ONS Brady Todd C
Director		 28,985 $0 153,288
(Direct)		 View
2016-11-23
Option Award		 2016-11-23
4:00 pm		 N/A
N/A		 Spring Bank Pharmaceuticals Inc. SBPH Brady Todd C
Director		 10,964 $9.12 10,964
(Direct)		 View
2016-11-23
Option Award		 2016-11-23
4:00 pm		 2017-05-24
2021-11-23		 Spring Bank Pharmaceuticals Inc. SBPH Brady Todd C
Director		 10,964 $0 10,964
(Direct)		 View
2017-03-03
Option Award		 2017-03-07
5:45 pm		 N/A
N/A		 Aldeyra Therapeutics Inc. ALDX Brady Todd C
CEO		 136,806 $0 201,214
(Direct)		 View
2017-03-03
Option Award		 2017-03-07
5:45 pm		 N/A
2027-03-02		 Aldeyra Therapeutics Inc. ALDX Brady Todd C
CEO		 250,000 $0 250,000
(Direct)		 View
2017-05-03
Option Award		 2017-05-05
5:58 pm		 N/A
2027-05-02		 Evoke Pharma Inc EVOK Brady Todd C
Director		 34,000 $0 34,000
(Direct)		 View
2017-06-15
Option Award		 2017-06-16
4:49 pm		 N/A
2027-06-14		 Spring Bank Pharmaceuticals Inc. SBPH Brady Todd C
Director		 5,500 $0 5,500
(Direct)		 View
2017-07-03
Option Award		 2017-07-05
4:08 pm		 N/A
N/A		 Spring Bank Pharmaceuticals Inc. SBPH Brady Todd C
Director		 645 $0 11,609
(Direct)		 View
2017-10-02
Option Award		 2017-10-03
4:04 pm		 N/A
N/A		 Spring Bank Pharmaceuticals Inc. SBPH Brady Todd C
Director		 633 $0 12,242
(Direct)		 View
2017-10-26
Option Award		 2017-10-30
6:03 pm		 N/A
2027-10-26		 Oncobiologics Inc. ONS Brady Todd C
Director		 15,000 $0 15,000
(Direct)		 View
2018-01-02
Option Award		 2018-01-03
4:12 pm		 N/A
N/A		 Spring Bank Pharmaceuticals Inc. SBPH Brady Todd C
Director		 852 $0 13,094
(Direct)		 View
2018-03-06
Option Award		 2018-03-08
4:40 pm		 N/A
N/A		 Aldeyra Therapeutics Inc. ALDX Brady Todd C
CEO		 101,269 $0 302,483
(Direct)		 View
2018-03-06
Option Award		 2018-03-08
4:40 pm		 N/A
2028-03-05		 Aldeyra Therapeutics Inc. ALDX Brady Todd C
CEO		 217,293 $0 217,293
(Direct)		 View
2018-04-26
Option Award		 2018-04-27
4:22 pm		 N/A
2028-04-25		 Evoke Pharma Inc EVOK Brady Todd C
Director		 34,000 $0 34,000
(Direct)		 View
2018-06-18
Option Award		 2018-06-19
4:28 pm		 N/A
2028-06-17		 Spring Bank Pharmaceuticals Inc. SBPH Brady Todd C
Director		 5,500 $0 5,500
(Direct)		 View
2019-03-05
Option Award		 2019-03-07
5:20 pm		 N/A
N/A		 Aldeyra Therapeutics Inc. ALDX Brady Todd C
CEO		 250,000 $0 556,054
(Direct)		 View
2019-03-05
Option Award		 2019-03-07
5:20 pm		 N/A
2029-03-04		 Aldeyra Therapeutics Inc. ALDX Brady Todd C
CEO		 250,000 $0 250,000
(Direct)		 View
2019-03-05
Option Award		 2019-03-07
5:20 pm		 N/A
N/A		 Aldeyra Therapeutics Inc. ALDX Brady Todd C
CEO		 45,329 $0 45,329
(Direct)		 View
2019-03-29
Option Award		 2019-04-02
4:03 pm		 N/A
N/A		 Spring Bank Pharmaceuticals Inc. SBPH Brady Todd C
Director		 1,180 $0 14,274
(Direct)		 View
2019-05-02
Option Award		 2019-05-03
5:44 pm		 N/A
2029-05-01		 Evoke Pharma Inc EVOK Brady Todd C
Director		 34,000 $0 34,000
(Direct)		 View
2019-06-28
Option Award		 2019-07-01
09:00 am		 N/A
N/A		 Spring Bank Pharmaceuticals Inc. SBPH Brady Todd C
Director		 3,354 $0 17,628
(Direct)		 View
2019-07-10
Option Award		 2019-07-11
08:55 am		 N/A
2029-07-09		 Spring Bank Pharmaceuticals Inc. SBPH Brady Todd C
Director		 7,500 $0 7,500
(Direct)		 View
2019-09-30
Option Award		 2019-10-01
4:47 pm		 N/A
N/A		 Spring Bank Pharmaceuticals Inc. SBPH Brady Todd C
Director		 3,597 $0 21,225
(Direct)		 View
2019-12-31
Option Award		 2020-01-02
5:09 pm		 N/A
N/A		 Spring Bank Pharmaceuticals Inc. SBPH Brady Todd C
Director		 7,832 $0 29,057
(Direct)		 View
2020-03-02
Option Award		 2020-03-04
7:44 pm		 N/A
N/A		 Aldeyra Therapeutics Inc. ALDX Brady Todd C
CEO		 250,000 $0 902,216
(Direct)		 View
2020-03-02
Option Award		 2020-03-04
7:44 pm		 N/A
2030-03-01		 Aldeyra Therapeutics Inc. ALDX Brady Todd C
CEO		 250,000 $0 250,000
(Direct)		 View
2020-03-02
Option Award		 2020-03-04
7:44 pm		 N/A
N/A		 Aldeyra Therapeutics Inc. ALDX Brady Todd C
CEO		 450,865 $0 450,865
(Direct)		 View
2020-03-31
Option Award		 2020-04-01
4:00 pm		 N/A
N/A		 Spring Bank Pharmaceuticals Inc. SBPH Brady Todd C
Director		 13,306 $0 42,363
(Direct)		 View
2020-05-27
Option Award		 2020-05-29
4:42 pm		 N/A
2030-05-26		 Evoke Pharma Inc EVOK Brady Todd C
Director		 57,750 $0 57,750
(Direct)		 View
2020-06-24
Option Award		 2020-06-25
4:00 pm		 N/A
2030-06-23		 Spring Bank Pharmaceuticals Inc. SBPH Brady Todd C
Director		 7,500 $0 7,500
(Direct)		 View
2020-06-30
Option Award		 2020-07-01
4:00 pm		 N/A
N/A		 Spring Bank Pharmaceuticals Inc. SBPH Brady Todd C
Director		 8,418 $0 50,781
(Direct)		 View
2020-09-30
Option Award		 2020-10-01
4:00 pm		 N/A
N/A		 Spring Bank Pharmaceuticals Inc. SBPH Brady Todd C
Director		 9,235 $0 60,016
(Direct)		 View
2020-11-19
Other		 2020-11-23
11:17 am		 2017-05-24
2021-11-23		 F-star Therapeutics Inc. SBPH Brady Todd C
Director		 2,741 $0 0
(Direct)		 View
2021-04-12
Option Award		 2021-04-14
7:23 pm		 N/A
N/A		 Aldeyra Therapeutics Inc. ALDX Brady Todd C
CEO		 46,619 $0 948,835
(Direct)		 View
2021-04-12
Option Award		 2021-04-14
7:23 pm		 N/A
2031-04-11		 Aldeyra Therapeutics Inc. ALDX Brady Todd C
CEO		 250,000 $0 250,000
(Direct)		 View
2021-06-04
Option Award		 2021-06-07
4:14 pm		 N/A
2031-06-04		 F-star Therapeutics Inc. FSTX Brady Todd C
Director		 20,000 $0 20,000
(Direct)		 View
2021-05-05
Option Award		 2021-07-23
6:15 pm		 N/A
2031-05-04		 Evoke Pharma Inc EVOK Brady Todd C
Director		 57,750 $0 57,750
(Direct)		 View